Phase 1 Single Ascending Dose Study of Intravenous Eravacycline in Volunteers.
Phase of Trial: Phase I
Latest Information Update: 15 Sep 2010
At a glance
- Drugs Eravacycline (Primary)
- Indications Gram-negative infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Tetraphase Pharmaceuticals
- 13 Sep 2010 Results have been presented at 2010 ICAAC, according to a Tetraphase Pharmaceuticals media release.
- 02 Jun 2010 New trial record